Interaction of bisphosphonates with calcitonin in monitoring medullary carcinoma of the thyroid.
We report the case history of a patient with long standing recurrent medullary carcinoma of the thyroid. Elevation of the serum marker calcitonin coincided with the introduction of biphosphonate therapy and recurrence of tumour was not established. The interaction of biphosphonates with calcitonin is not previously recorded.
Osborne
M E
ME
The Cancer Centre, Mount Vernon Hospital, Northwood, Middlesex, UK.
Brown
R S
RS
Hoskin
P J
PJ
D000328:Adult; D002116:Calcitonin / Q000097:blood*; D018276:Carcinoma, Medullary / Q000097:blood* / Q000473:pathology; D004164:Diphosphonates / Q000097:blood* / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy; D013964:Thyroid Neoplasms / Q000097:blood* / Q000473:pathology
D004164:Diphosphonates; D002116:Calcitonin